Consistent with an inhibitory role, G1, a selective GPER‐1 agonist, inhibited the proliferation of ovarian cancer cell lines (SKOV‐3 and OVCAR‐3) (Langdon et al. 2020). Here, GPER1 is linked to ovarian cancer.